Market Overview The semaglutide market is experiencing competition emphasis where rival agents, biosimilars, and next-generation therapies drive innovation and market dynamics. The semaglutide market is projected to exceed USD 12.4 billion through 2030, with competition emphasis driven by market opportunity, innovation incentive, and therapeutic expansion. Competitive semaglutide landscape...